Keywords: fda, backs, merck, co, emend, before, panel

FDA backs Merck & Co's Emend before panel meeting

Article | 10 March 2003

Print This

The US Food and Drug Administration has issued a memo in which itsupports the view that Merck & Co's Emend (aprepitant) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in